Arnaud Lacoste, PhD, on AURN001‘s Immunomodulatory Properties
The chief scientific officer of Aurion Biotech discussed the properties of the cell therapy for corneal dystrophies, which was recently approved in Japan.
Arnaud Lacoste, PhD, on Addressing Unmet Needs in Corneal Dystrophies
The chief scientific officer of Aurion Biotech discussed the investigational cell therapy AURN001.